Vertex Pharmaceuticals Stock Forecast

Stock Price Forecast

The 22 analysts with 12-month price forecasts for VRTX stock have an average target of 496.27, with a low estimate of 370 and a high estimate of 600. The average target predicts an increase of 7.15% from the current stock price of 463.15.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$370	$496.27	$509	$600
Change	-20.11%	+7.15%	+9.90%	+29.55%

Analyst Ratings

The average analyst rating for VRTX stock from 26 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Apr '24	May '24	Jun '24	Jul '24	Aug '24	Sep '24
Strong Buy	7	6	8	8	9	9
Buy	12	11	11	10	9	9
Hold	6	6	6	6	7	7
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	26	24	26	25	26	26

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brian Abrahams RBC Capital	RBC Capital	Hold Reiterates $431	Hold	Reiterates	$431	-6.94%	Sep 19, 2024
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $500 → $600	Strong Buy	Maintains	$500 → $600	+29.55%	Aug 5, 2024
Hartaj Singh Oppenheimer	Oppenheimer	Buy Maintains $500 → $550	Buy	Maintains	$500 → $550	+18.75%	Aug 5, 2024
Jessica Fye JP Morgan	JP Morgan	Buy Maintains $505 → $510	Buy	Maintains	$505 → $510	+10.12%	Aug 5, 2024
Joon Lee Truist Securities	Truist Securities	Strong Buy Reiterates $508 → $550	Strong Buy	Reiterates	$508 → $550	+18.75%	Aug 5, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

10.97B

from 9.87B

11.15%

from 9.87B

Revenue Next Year

11.98B

from 10.97B

9.16%

from 10.97B

EPS This Year

0.33

from 13.89

-97.64%

from 13.89

EPS Next Year

18.09

from 0.33

5,414.70%

from 0.33

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.16B	6.21B	7.57B	8.93B	9.87B	10.97B	11.98B	13.24B
Revenue Growth	36.59%	49.08%	22.06%	17.91%	10.51%	11.15%	9.16%	10.58%
EPS	4.51	10.29	9.01	12.82	13.89	0.33	18.09	19.39
EPS Growth	-44.24%	128.16%	-12.44%	42.29%	8.35%	-97.64%	5,414.70%	7.19%
Forward PE	-	-	-	-	-	1,411.77	25.60	23.88
No. Analysts	-	-	-	-	-	36	35	25

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	11.5B	14.4B	16.3B
Avg	11.0B	12.0B	13.2B
Low	10.0B	10.9B	11.5B

Revenue Growth

Revenue Growth	2024	2025	2026
High	16.3%	31.4%	36.1%
Avg	11.2%	9.2%	10.6%
Low	1.5%	-0.5%	-3.6%

EPS Forecast

EPS	2024	2025	2026
High	3.80	24.30	24.31
Avg	0.33	18.09	19.39
Low	-0.35	1.46	2.00

EPS Growth

EPS Growth	2024	2025	2026
High	-72.6%	7,306.2%	34.4%
Avg	-97.6%	5,414.7%	7.2%
Low	-	345.1%	-88.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.